BioSpace News Archive

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its ABO-202 program

Nashville based patient financing company increases patients served by more than 80% since moving headquarters to Nashville in 2017.

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, has unveiled a new, state-of-the-art clinical and niche commercial facility to support pharmaceutical and biotechnology companies throughout the development and manufacture of active pharmaceutical ingredients (API).

Investments in new facility to also significantly expand Valens’ white label and private label product development capacity

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, announced it has licensed ORM-12741 from Orion Corporation.

Phase IIIb study met all primary and secondary endpoints with statistical significance and demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C

ArQule, Inc. announced that Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the BMO Prescriptions for Success Healthcare Conference on June 25, 2019 at 8:00 a.m. ET at the The Mandarin Oriental New York, New York.

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

Protagonist Therapeutics, Inc. reported that on June 17, 2019, it issued an inducement award to Nishit Modi, Ph.D., the Company’s recently hired Vice President of Clinical Pharmacology, in accordance with the terms of Dr.

Kewaunee Scientific Corporation announced results for its fourth quarter and its fiscal year ended April 30, 2019.